Cas:56153-45-8 4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide manufacturer & supplier

Chemical Name:4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide

CAS.NO:56153-45-8

Synonyms:4-Oxo-2,6-diphenyl-4H-4lambda*5*-[1,4]oxaphosphinin-4-ol;HMS1769H06;4-hydroxy-2,6-diphenyl-4H-1,4-oxaphosphorin 4-oxide;4-hydroxy-2,6-diphenyl-1,4;2,6-Diphenyl-4H-1,4-oxaphosphorin-4-ol-4-oxid;4-hydroxy-2,6-diphenyl-1,4-oxaphosphorin 4-oxide

Molecular Formula:C₁₆H₁₃O₃P

Molecular Weight:284.24600

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:551.3ºC at 760 mmHg

Density:1.33g/cm3

Index of Refraction:1.646

PSA:56.34000

Exact Mass:284.06000

LogP:4.28420

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Oxo-2,6-diphenyl-4H-4lambda*5*-[1,4]oxaphosphinin-4-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxy-2,6-diphenyl-1,4-oxaphosphorin 4-oxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-hydroxy-2,6-diphenyl-1,4-oxaphosphorin 4-oxide Use and application,HMS1769H06 technical grade,usp/ep/jp grade.

Related News: The resort island of Jeju off the south coast of South Korea, a popular destination for Chinese tourists, is temporarily suspending the 30-day no-visa entry that it was granting to Chinese and other foreign tourists. 4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide manufacturer ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide supplier  The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide vendor These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. 4-hydroxy-2,6-diphenyl-1,4λ5-oxaphosphinine 4-oxide factory ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.